Advertisement
COLL vs MTH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COLL is a Buy and MTH is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COLL’s FA Score shows that 0 FA rating(s) are green whileMTH’s FA Score has 2 green FA rating(s).
- COLL’s FA Score: 0 green, 5 red.
- MTH’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COLL’s TA Score shows that 6 TA indicator(s) are bullish while MTH’s TA Score has 6 bullish TA indicator(s).
- COLL’s TA Score: 6 bullish, 4 bearish.
- MTH’s TA Score: 6 bullish, 4 bearish.
Price Growth
COLL (@Pharmaceuticals: Generic) experienced а +2.98% price change this week, while MTH (@Homebuilding) price change was +6.83% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.80%. For the same industry, the average monthly price growth was +29.15%, and the average quarterly price growth was +14.69%.
The average weekly price growth across all stocks in the @Homebuilding industry was +3.01%. For the same industry, the average monthly price growth was +16.66%, and the average quarterly price growth was +5.12%.
Reported Earning Dates
COLL is expected to report earnings on Jul 30, 2026.
MTH is expected to report earnings on Jul 29, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (+3.80% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Homebuilding (+3.01% weekly)Homebuilding includes companies residential home construction companies, renovators and repair firms. The companies may be building single-family or multifamily homes, condominiums or mobile homes. Over the five years to 2019, the Home Builders industry is estimated to have grown at an annualized rate of 2.5% to reach $89.4 billion, (including expected growth of 2.6% in 2019), according to a study by IbisWorld. After having suffered one of its worst crises a decade ago during the last macroeconomic recession–which had much of its origins in U.S. real estate – the homebuilding industry has been recovering steadily so far. Higher disposable incomes and improving economic activity have bolstered consumers’ purchases of homes. While revenue of the Home Builders industry remains well below its prerecession high, demand growth estimates show promise.
| COLL | MTH | COLL / MTH | |
| Capitalization | 1.11B | 4.86B | 23% |
| EBITDA | 411M | 522M | 79% |
| Gain YTD | -26.004 | 11.626 | -224% |
| P/E Ratio | 16.63 | 13.30 | 125% |
| Revenue | 796M | 5.62B | 14% |
| Total Cash | 422M | 767M | 55% |
| Total Debt | 808M | 1.9B | 42% |
COLL | MTH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 6 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 52 Fair valued | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 66 | 69 | |
SMR RATING 1..100 | 36 | 80 | |
PRICE GROWTH RATING 1..100 | 59 | 43 | |
P/E GROWTH RATING 1..100 | 82 | 10 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MTH's Valuation (7) in the Homebuilding industry is somewhat better than the same rating for COLL (52) in the Pharmaceuticals Other industry. This means that MTH’s stock grew somewhat faster than COLL’s over the last 12 months.
COLL's Profit vs Risk Rating (66) in the Pharmaceuticals Other industry is in the same range as MTH (69) in the Homebuilding industry. This means that COLL’s stock grew similarly to MTH’s over the last 12 months.
COLL's SMR Rating (36) in the Pharmaceuticals Other industry is somewhat better than the same rating for MTH (80) in the Homebuilding industry. This means that COLL’s stock grew somewhat faster than MTH’s over the last 12 months.
MTH's Price Growth Rating (43) in the Homebuilding industry is in the same range as COLL (59) in the Pharmaceuticals Other industry. This means that MTH’s stock grew similarly to COLL’s over the last 12 months.
MTH's P/E Growth Rating (10) in the Homebuilding industry is significantly better than the same rating for COLL (82) in the Pharmaceuticals Other industry. This means that MTH’s stock grew significantly faster than COLL’s over the last 12 months.
| COLL | MTH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 70% |
| Stochastic ODDS (%) | 1 day ago 71% | 1 day ago 69% |
| Momentum ODDS (%) | 1 day ago 69% | 1 day ago 62% |
| MACD ODDS (%) | 1 day ago 74% | 1 day ago 59% |
| TrendWeek ODDS (%) | 1 day ago 68% | 1 day ago 71% |
| TrendMonth ODDS (%) | 1 day ago 69% | 1 day ago 69% |
| Advances ODDS (%) | 6 days ago 70% | 4 days ago 70% |
| Declines ODDS (%) | 14 days ago 65% | 13 days ago 71% |
| BollingerBands ODDS (%) | 1 day ago 75% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 69% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IQLT | 49.37 | 0.21 | +0.42% |
| iShares MSCI Intl Quality Factor ETF | |||
| FSYD | 48.98 | 0.11 | +0.23% |
| Fidelity Sustainable High Yield ETF | |||
| EMDV | 46.71 | N/A | N/A |
| ProShares MSCI Emerg Mkts Div Growers | |||
| CCFE | 27.61 | N/A | N/A |
| Concourse Capital Focused Equity ETF | |||
| RSPH | 32.09 | -0.07 | -0.22% |
| Invesco S&P 500® Equal Wt Hlth Care ETF | |||
MTH and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTH has been closely correlated with KBH. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTH jumps, then KBH could also see price increases.